Adefegha SA, Adesua OO, Oboh G (2023) Evaluation of combined antioxidant potential of p-coumaric acid and/or lisinopril—in vitro and in vivo. Comp Clin Pathol 32(6):1035–1043

Article  CAS  Google Scholar 

Ahmad H, Khan H, Haque S, Ahmad S, Srivastava N, Khan A (2023) Angiotensin-converting enzyme and hypertension: a systemic analysis of various ACE inhibitors, their side effects, and bioactive peptides as a putative therapy for hypertension. J Renin-Angiotensin-Aldosterone Syst 2023:7890188

Ahmed GM, Abed MN, Alassaf FA (2024) Impact of calcium channel blockers and angiotensin receptor blockers on hematological parameters in type 2 diabetic patients. Naunyn Schmiedebergs Arch Pharmacol 397(3):1817–1828

Article  CAS  PubMed  Google Scholar 

Alcocer LA, Bryce A, De Padua BD, Lara J, Cortes JM, Quesada D et al (2023) The pivotal role of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in hypertension management and cardiovascular and renal protection: a critical appraisal and comparison of international guidelines. Am J Cardiovasc Drugs 23(6):663–682

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ali GM, Seme WAE, Dudhat K (2024) Examining the difficulties in identifying and handling cardiac amyloidosis: acquiring important knowledge and robust treatment methods. Cardiovasc Haematol Disord-Drug Targets (rug Targets-Cardiovascular & Hematological Disorders) 24(2):65–82

Al-Khalaf IS, Altaei T, Alani R (2023) Impact of angiotensin receptor blockers on angiotensin III and leptin in rabbits. Biomed Pharmacol Jo 16(4):2425–2438

Article  CAS  Google Scholar 

Al-Shahi Salman R, Greenberg SM (2023) Antiplatelet agent use after stroke due to intracerebral hemorrhage. Stroke 54(12):3173–3181

Article  PubMed  Google Scholar 

Alves-Lopes R, Montezano AC, Neves KB, Harvey A, Rios FJ, Skiba DS et al (2021) Selective inhibition of the C-domain of ACE (angiotensin-converting enzyme) combined with inhibition of NEP (Neprilysin): a potential new therapy for hypertension. Hypertension 78(3):604–616

Article  CAS  PubMed  Google Scholar 

Andersen S, Axelsen JS, Nielsen-Kudsk AH, Schwab J, Jensen CD, Ringgaard S et al (2024) Effects of dopamine β-hydroxylase inhibition in pressure overload-induced right ventricular failure. Pulm Circ 14(4):e70008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Antar V, Baran O, Yuceli S et al (2018) Assessment of the neuroprotective effects of the acetylcholinesterase inhibitor huperzine A in an experimental spinal cord trauma model. J Neurosurg Sci 62(2):128–139

Article  PubMed  Google Scholar 

Avery EG, Bartolomaeus H, Rauch A, Chen C-Y, N’Diaye G, Löber U et al (2023) Quantifying the impact of gut microbiota on inflammation and hypertensive organ damage. Cardiovasc Res 119(6):1441–1452

Article  CAS  PubMed  Google Scholar 

Azizi M (2021) Aldosterone receptor antagonists. Annales d’Endocrinologie 82(3):179–181

Article  PubMed  Google Scholar 

Bain A (2019) Use of calcium channel blockers in cardiovascular disease. Br J Cardiac Nurs 14(2):64–70

Article  Google Scholar 

Barracano R, Ciriello GD, Sarubbi B (2023) Pharmacological therapy in adult congenital heart disease with coronary artery disease and atrial fibrillation. Int J Cardiol Congenit Heart Dis 12:100446

Article  PubMed  PubMed Central  Google Scholar 

Bavishi C, Messerli FH, Kadosh B, Ruilope LM, Kario K (2015) Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials. Eur Heart J 36(30):1967–1973

Article  CAS  PubMed  Google Scholar 

Beevers G, Lip GY, O’Brien E (2001) The pathophysiology of hypertension. BMJ 322(7291):912–916

Article  CAS  PubMed  PubMed Central  Google Scholar 

Belli M, Barone L, Longo S, Prandi FR, Lecis D, Mollace R et al (2023) Gut microbiota composition and cardiovascular disease: a potential new therapeutic target? Int J Mol Sci 24(15):11971

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biffi A, Dell’Oro R, Quarti-Trevano F, Cuspidi C, Corrao G, Mancia G et al (2023) Effects of renal denervation on sympathetic nerve traffic and correlates in drug-resistant and uncontrolled hypertension: a systematic review and meta-analysis. Hypertension 80(3):659–667

Article  CAS  PubMed  Google Scholar 

Chaitoff A, Zheutlin AR (2024) Epidemiology of hypertension in older adults. Clin Geriatr Med 40:515–528

Article  PubMed  Google Scholar 

Chakaroun RM, Olsson LM, Bäckhed F (2023) The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease. Nat Rev Cardiol 20(4):217–235

Article  PubMed  Google Scholar 

Charles L, Triscott J, Dobbs B (2017) Secondary hypertension: discovering the underlying cause. Am Fam Physician 96(7):453–461

PubMed  Google Scholar 

Chen X, Huang M, Chen Y, Xu H, Wu M (2024) Mineralocorticoid receptor antagonists and heart failure with preserved ejection fraction: current understanding and future prospects. Heart Fail Rev 1–18

Chen X, Li X, Zhang K, Lian K, Zhang W, Song Y et al (2024a) The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances. Clin Exp Nephrol 28(2):125–135

Article  PubMed  Google Scholar 

Chiamvimonvat N, Ho C-M, Tsai H-J, Hammock BD (2007) The soluble epoxide hydrolase as a pharmaceutical target for hypertension. J Cardiovasc Pharmacol 50(3):225–237

Article  CAS  PubMed  Google Scholar 

Cho M, Choi C-Y, Choi YJ, Rhie SJ (2023) Clinical outcomes of renin angiotensin system inhibitor-based dual antihypertensive regimens in chronic kidney disease: a network meta-analysis. Sci Rep 13(1):5727

Article  CAS  PubMed  PubMed Central  Google Scholar 

Constantinescu T, Mihis AG (2023) Resveratrol as a privileged molecule with antioxidant activity. Food Chem Adv 3:100539

Article  Google Scholar 

Crawford MH (2014) Angiotensin receptor blockers for hypertension. Internal Med Alert 36(20):1732–1742

Google Scholar 

Cruz Rodriguez JB, Alkhateeb H (2020) Beta-blockers, calcium channel blockers, and mortality in stable coronary artery disease. Curr Cardiol Rep 22:1–5

Article  Google Scholar 

Cui X, Zhang T, Xie T, Guo F-X, Zhang Y-Y, Deng Y-J et al (2024) Research progress on the correlation between hypertension and gut microbiota. J Multidisc Healthc 17:2371–87

Article  Google Scholar 

Cutrell S, Alhomoud IS, Mehta A, Talasaz AH, Van Tassell B, Dixon DL (2023) ACE-inhibitors in hypertension: a historical perspective and current insights. Curr Hypertens Rep 25(9):243–250

Article  CAS  PubMed  Google Scholar 

da Silva MV, da Silva Lima MA, de Farias LH, Dos Santos VM, de Queiroz TM (2023) Isolated natural antioxidants as a new possible therapeutic alternative for the treatment of hypertension. Curr Hypertens Rev 19(1):7–18

Article  PubMed  Google Scholar 

Dai Y, Shen Z, Khachatryan LG, Vadiyan DE, Karampoor S, Mirzaei R (2023) Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: a comprehensive review. Pathol-Res Pract 249:154740

Article  CAS  PubMed  Google Scholar 

Dalal J, Chandra P, Ray S, Hazra P, Hiremath J, Kumar V et al (2023) Practical recommendations for the use of angiotensin receptor-neprilysin inhibitors (ARNI) in heart failure: insights from Indian cardiologists. Cardiol Ther 12(3):445–471

Article  PubMed  PubMed Central  Google Scholar 

de la Sierra A, Oliveras A (2024) New therapeutic targets in hypertension. Med Clín Engl Ed 163:301–305

Google Scholar 

Dogra S, Shah S, Gitzel L, Pusukur B, Sood A, Vyas AV et al (2023) Baxdrostat: a novel aldosterone synthase inhibitor for treatment resistant hypertension. Curr Probl Cardiol 48(11):101918

Article  PubMed  Google Scholar 

Dominguez Rieg JA, Rieg T (2024) New functions and roles of the Na+-H+-exchanger NHE3. Pflügers Archiv-Eur J Physiol 476(4):505–516

Article  CAS  Google Scholar 

Eisenberg MJ, Brox A, Bestawros AN (2004) Calcium channel blockers: an update. Am J Med 116(1):35–43

Article  CAS  PubMed